08:51 AM EDT, 07/12/2024 (MT Newswires) -- Enovis ( ENOV ) said Friday it has expanded its AltiVate Reverse shoulder implants to include modular, augmented baseplates.

The AltiVate Reverse glenoid system received US Food and Drug Administration clearance in May for reverse shoulder arthroplasty, including revisions.

Enovis ( ENOV ) said reverse shoulder arthroplasties represent over 60% of the more than 200,000 shoulder replacements performed annually in the US.